Skip to content

Comparison of two different formulations of ropivacaine in spinal anaesthesia for patients undergoing surgeries

Effect of baricity on subarachnoid block characteristics of ropivacaine in infraumbilical surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046420
Enrollment
66
Registered
2022-10-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 3ml Hyperbaric 0.75% Ropivacaine will be injected intrathecally for subarachnoid blockade at the time of induction: Hyperbaric 0.75% Ropivacaine will be injected intrathecally for sub

Sponsors

Maulana Azad medical college and associated Lok Nayak, G.N.E.C and G.I.P.M.E.R Hospitals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA 1 and 2 2.Systolic blood pressure 110-140 mmHg 3.BMI less than or equal to 30Kg/m2 4.Height 150-180

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating patients 2.Patient with hepatic, cardiovascular or renal dysfunction 3.Patients having epilepsy, neurological, coagulation disorder 4.Contraindication to spinal anaesthesia 5.Any allergy to the study drug 6.Elective surgery more than 2 hour duration 7.Surgeries requiring patient position other than supine

Design outcomes

Primary

MeasureTime frame
Duration of 2 segment regression of sensory blockade from maximum blockTimepoint: 2 hour

Secondary

MeasureTime frame
Onset and duration of sensory block and motor blockTimepoint: 6 hours;Maximum level of sensory block achievedTimepoint: 6 hours;Time to maximum level of motor blockTimepoint: 6 hours

Countries

India

Contacts

Public ContactDR LALIT GUPTA

Maulana Azad Medical College

lalit.doc@gmail.com9868092739

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026